Delivery Order SPE2DB22D1200-SPE2DB25FM9AM

Award Date 11/15/24
Potential Completion Date 11/18/24
Potential Value $3.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,134.18 firm fixed-price delivery order is for the supply of QULIPTA 60 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of November 20, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,488.28 firm fixed-price delivery order is for the supply of QULIPTA 60 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of May 21, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award, with the ID SPE2DB22D1002|SPE2DB25FKTX1, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,867.49 Firm Fixed Price delivery order contract is for the supply of Qulipta 60 mg tablet medication, with a completion date of November 7, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of Qulipta 60 mg tablets. The $1,154.79 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical and medical supplies to support military...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The $8,353.23 delivery order contract is for the supply of Qulipta 30 mg tablets, a prescription medication. The contract has a firm-fixed price and an ultimate completion date of August 21, 2024. This award is likely part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $1,116.21 Firm Fixed Price delivery order is for the drug Qulipta 60 mg tablet, with an ultimate completion date of July 1, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Qulipta 60 mg tablets. The contract has a ceiling value of $3,063.02 and is a firm fixed-price delivery order contract with a period of performance through July 10, 2024. The contract does not have a set-aside designation, indicating it was competitively awarded. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,128.65 firm fixed-price delivery order is for the supply of QULIPTA 60 MG TABLET 30S, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of December 20, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Qulipta 60 mg tablets. The contract has a ceiling value of $2,758.76 and an ultimate completion date of July 19, 2024. The order is placed under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a wide range of pharmaceutical and medical...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,154.79 firm fixed-price delivery order is for the supply of QULIPTA 60 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of January 28, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary...
  • SPE2DB22D1200
    Indefinite Delivery Contract
  • SPE2DB22D1200-SPE2DB25FM9AM
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,137.48 firm fixed-price delivery order is for Qulipta 60 mg tablets and has a completion date of November 18, 2024.

Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order appears to be a task order issued under that broader IDC, enabling efficient government procurement of essential medical commodities. The contract does not have a set-aside designation, indicating open competition.

Generated 2/14/25, 9:13 AM